archiveeli lilly stock

LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. ... More Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Getty Images)Peter Dazeley Question: Why would you pay 81 times earnings for AbbVie stock when you can buy LLY for a similar valuation of 76 times earnings? You wouldn’t, especially when you consider three simple facts: Growth: Eli Lilly's growth rate is accelerating at over 30%, dwarfing AbbVie's under 5%. Over the last three...

CANADA - 2025/04/02: In this photo illustration, the Eli Lilly and Company logo is seen displayed on ... More a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Eli Lilly’s (NYSE: LLY) first-quarter performance was mixed, with revenue meeting expectations but earnings falling short. The company reported adjusted earnings of $3.34 per share versus the projected $3.46, while revenue reached $12.7 billion, aligning with consensus estimates. Although Eli Lilly experienced lower price realization, the strong volume growth for its key drugs contributed positively...